than in the supratentorial group (P = 0.024). In the non-plaque type cases (n = 53), the infratentorial group developed vertigo more frequently than the supratentorial group (P = 0.017); moreover, cerebellar signs appeared more frequently in the infratentorial group (P = 0.014). However, there was no significant difference between the groups in the plaque type (n = 18).
Conclusions:
The high frequency of clinical manifestations related to brain stem and cerebellar dysfunction in the non-plaque type dCJD with infratentorial grafting suggests that PrP Sc commonly shows direct propagation into the CNS from contaminated dura mater grafts.
(268 words) ・ We analyzed the clinical data taking into account not only grafting site but also the pathological subtypes of dCJD.
Key messages
・ Infratentorial grafting cases in non-plaque type developed manifestations related to dysfunction of the brain stem and cerebellum more frequently than supratentorial grafting cases.
・ Cerebellar signs also appeared more frequently in the infratentorial group during their clinical course.
・ Plaque type cases showed no significant difference between the supratentorial and the infratentorial groups.
Strengths and limitations of this study
・ This study suggests that the non-plaque type abnormal prion protein (PrP Sc ) strain would propagate from grafted dura mater to the adjacent brain directly and damage it earlier and more severely.
・ It would be difficult to determine focal brain lesions by PrP Sc accumulation and subsequent neuronal damage from only information about clinical manifestations.
・ Another limitation of this study includes the relatively small number of plaque-type patients, which demonstrated no noteworthy results.
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Introduction
Dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) is an acquired
Creutzfeldt-Jakob disease (CJD) related to previous dura mater graft transplantation. 1,2 Details of abnormal prion protein (PrP Sc ) propagation in the human central nervous system (CNS) are not fully understood. 3 Previous studies of dCJD cases disclosing the relationship between initial manifestation and the site of grafting proposed that PrP Sc may propagate directly from the contaminated dura mater graft to the adjacent brain regions and may spread from the initially infected regions to other brain regions. [4] [5] [6] In the previous studies of dCJD case series, however, the results were obtained without considering dCJD pathological subtypes. 5, 6 There are 2 subtypes of dCJD: non-plaque type and plaque type. [7] [8] [9] These subtypes arise from 2 distinct prion strains. [7] [8] [9] Each prion strain has different characteristics of incubation period and neuropathological features when inoculated into defined inbred mice; 8, 10 it was proposed that each prion strain must 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   Sakai 8 show a distinct propagation process in the human brain. 10 Therefore, the disease pathological subtypes (prion strains) should be taken into consideration when clinical features are analyzed in dCJD cases. This study made use of the prospective prion disease surveillance in Japan, to analyze clinical manifestations of dCJD cases taking into account not only their grafting sites but also their pathological subtypes.
Materials and Methods
Patients
In Japan, the prospective surveillance of human prion disease by the CJD Surveillance 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   Sakai 9 with previous medical procedures which might be related to CJD, details of the information were collected, and the diagnosis of iatrogenic CJD was decided carefully.
Iatrogenic CJD was also diagnosed and categorized (definite, probable, and possible) using the criteria for sporadic CJD. In patients with iatrogenic CJD, the diagnosis of dCJD was decided by confirmation of dura mater grafting. The clinical features of dCJD for all patients, the supratentorial group, and the infratentorial group are summarized in Table 1 . The proportion of females in the infratentorial group was larger than that in the supratentorial group (P = 0.015). Age at dural grafting, incubation period, or age at CJD onset showed no significant difference between the 2 groups. Regarding initial manifestations, vertigo (31% and 3%; P = 0.007) and diplopia (15% and 0%; P = 0.041) were more frequently observed in the infratentorial group than in the supratentorial group. Dementia and behavioral abnormality suggesting dysfunction of the cerebrum demonstrated no significant difference between the groups. In the infratentorial group, 8 cases (31%) developed Results from the analysis of the non-plaque type cases were similar to those of the sample population as a whole (Table 2) . Vertigo was more frequently observed as an initial manifestation in the infratentorial group than in the supratentorial group (32% and 0%; P = 0.017). There was a trend in the increase of diplopia frequency in the infratentorial group (21% and 0%; P = 0.074). Dementia and behavioral abnormalities demonstrated no significant difference between the 2 groups. In the infratentorial group, 7 cases (37%) demonstrated dementia or behavioral abnormalities as initial manifestations. Similar to the analysis of the sample population as a whole, the median incubation period of cases developing dementia or behavioral abnormalities showed no significant difference between the supratentorial and infratentorial groups (data not shown). Cerebellar signs were significantly more often realized in the infratentorial group during their clinical course than in the supratentorial group (87% and 50%; P = 0.041). In contrast, there was no significant difference between the supratentorial group and the infratentorial group concerning initial manifestations or manifestations during their clinical course in the analysis of the plaque type cases (Table 3) .
Discussion
In this study of dCJD cases, we have reported that infratentorial grafting cases in not only the sample population as a whole but also the non-plaque type cases developed manifestations related to dysfunction of the brain stem and cerebellum more frequently than supratentorial grafting cases. Moreover, cerebellar signs appeared more frequently in the infratentorial group during their clinical course. In contrast, plaque type cases showed no significant difference between the supratentorial and the infratentorial groups.
These results suggest that the non-plaque type PrP Sc strain would propagate from 
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